Podcasts
Fresh Start: CohnReznick's Sherman, The Deal's Meagher Talk Distressed SPACs
By Stephanie Gleason
|
Published: March 6th, 2023
The pair discuss how companies that went public a year ago are winding up in Chapter 11.
News & Media
Industry news curated and delivered to inform your dealmaking strategies. We select the most relevant information, providing a consistent, convenient source for exclusive intelligence and analysis.
All News Activism Mergers & Acquisitions Podcasts Private Equity Restructuring Scoops & Exclusives SPACs Videos
Page 2
Activism
Activist Investing Today: Gojkovich Talks Universal Contests, Proxy Advisers, 'Activated' Managers
By Ronald Orol
|
Published: March 3rd, 2023
Lauren Gojkovich, who switched sides to advise activists at LDG Advisory, discusses prospects for 'activated' historically passive institutions and why the universal card in contests could reduce proxy adviser influence.
Mergers & Acquisitions
Drinks With The Deal: Skadden's Nijjar Discusses Tech M&A Boom, Memories of Bear Stearns
By David Marcus
|
Published: February 23rd, 2023
On the most recent Drinks With The Deal, Skadden M&A partner Sonia Nijjar discusses her work on the sale of Bear Stearns, her transition to a tech M&A practice and advising Activision and Elon Musk last year.
Activism
Activist Investing Today: ZMH's Hassan Talks Nominations, Masimo, Disney
By Ronald Orol
|
Published: February 23rd, 2023
Waheed Hassan, who has advised on major proxy contests at Huntsman, U.S. Foods and LivePerson, discusses activist director recruitment, Masimo's now removed bylaws and Nelson Peltz's battle at Disney.
Podcasts
Drinks With The Deal: Nixon Peabody's O'Keefe on Advising Founders
By David Marcus
|
Published: February 16th, 2023
Amy O'Keefe, an M&A and PE partner at Nixon Peabody in Boston, discusses the rewards and challenges of advising founders on the sales of their companies on this week's Drinks With The Deal podcast.
Mergers & Acquisitions
Talking M&A: Trends in Healthtech and Biotech M&A
By Deal Contributors
|
Published: February 7th, 2023
Baker McKenzie partner Aarthi Belani, AbbVie head of immunology business development and acquisitions Rachel Strick, Flare Capital Partners co-founder Michael Greeley and Patient Square Capital founding partner Neel Varshney share their insights on M&A trends in the sectors for the third episode of the Talking M&A podcast.
Mergers & Acquisitions
Drinks With The Deal: Wilson's Pavri on Dealmaking in Silicon Valley
By David Marcus
|
Published: February 2nd, 2023
Rezwan Pavri, a securities and M&A partner at Wilson Sonsini in Palo Alto, talks about balancing the two practices and the challenges his clients are facing in the most recent Drinks With The Deal podcast.
Activism
Activist Investing Today: White & Case’s Matthews, Tolani on Insurgents, Deals
By Ronald Orol
|
Published: January 26th, 2023
The U.K.-based attorneys, who advise both activists and companies, explain why they are seeing a trend of insurgent managers partnering with PE to try to buy companies they previously targeted with agitation campaigns.
Podcasts
Drinks With The Deal: Dechert's Macarchuk Talks Asset Management Convergence
By David Marcus
|
Published: January 20th, 2023
Nicole Macarchuk's career as a PE lawyer in house and at law firms has paralleled the evolution of the asset management industry as PE sponsors, hedge funds and credit funds have increasingly crossed into each other's markets.
